Japanese and North American/European patients with Beckwith-Wiedemann syndrome have different frequencies of some epigenetic and genetic alterations

European Journal of Human Genetics

Volumn 15, Issue 12, 2007, Pages 1205-1210

  Sasaki, Kensaku ^a   Soejima, Hidenobu ^a   Higashimoto, Ken ^a   Yatsuki, Hitomi ^a   Ohashi, Hirofumi ^b   Yakabe, Shinya ^a   Joh, Keiichiro ^a   Niikawa, Norio ^c,d   Mukai, Tsunehiro ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; EUROPE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; JAPANESE; NORTH AMERICA; PRIORITY JOURNAL; UNIPARENTAL DISOMY;

ASIAN CONTINENTAL ANCESTRY GROUP; BECKWITH-WIEDEMANN SYNDROME; EPIGENESIS, GENETIC; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; JAPAN; MUTATION; NORTH AMERICA; UNIPARENTAL DISOMY;

EID: 36349015367     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201912     Document Type: Article

References (18)

1. Weksberg R, Shuman C, Smith AC: Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2005; 137: 12-23.
2. DeBaun MR, Tucker MA: Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998; 132: 398-400.
3. Soejima H, Nakagawachi T, Zhao W et al: Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene 2004; 23: 4380-4388.
4. Satoh Y, Nakadate H, Nakagawachi T et al: Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours. Br J Cancer 2006; 95: 541-547.
5. Itoh N, Becroft DM, Reeve AE, Morison IM: Proportion of cells with paternal 11p15 uniparental disomy correlates with organ enlargement in Wiedemann-Beckwith syndrome. Am J Med Genet 2000; 92: 111-116.
6. Hatada I, Ohashi H, Fukushima. Y et al: An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 1996; 14 171-173.
7. Mannens M, Hoovers JM, Redeker E et al: Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur J Hum Genet 1994; 2 3-23.
8. Hatada J, Nabetani A, Morisaki H et al: New p57KIP2 mutations in Beckwith-Wiedemann syndrome. Hum Genet 1997; 100: 681-683.
9. Sparago A, Cerrato F, Vernucci M, Ferrero GB, Silengo MC, Riccio A: Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 2004; 36: 958-960.
10. Prawitt D, Enklaar T, Gartner-Rupprecht B et al: Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci USA 2005; 102: 4085-4090.
11. Sparago A, Russo S, Cerrato F et al: Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. Hum Mol Genet 2007; 16: 254-264.
12. Weksberg R, Nishikawa J, Caluseriu O et al: Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 2001; 10: 2989-3000.
13. Rump P, Zeegers MP, van Essen AJ: Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. Am J Med Genet A 2005; 136: 95-104.
14. Kobayashi Y. Malformation syndromes and childhood tumors; in Shimizu K, Misugi K (eds): Shouni Geka Byourigaku (Pediatric Surgical Pathology) Tokyo: Bunkodo, 1995, pp 12-18.
15. Fukuzawa R, Breslow NE, Morison IM et al: Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet 2004; 363: 446-451.
16. Gaston V, Le Bouc Y, Soupre V et al: Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2001; 9: 409-418.
17. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg, AP: Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002; 70: 604-611.
18. Bliek J, Gicquel C, Maas S, Gaston V, Le Bouc Y, Mannens M: Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 2004; 145: 796-799.